Document:

Exhibit
10.17

      

    FIFTH
AMENDMENT TO SECURITIES PURCHASE AGREEMENT

     

    THIS
FIFTH AMENDMENT TO SECURITIES PURCHASE AGREEMENT is made on October 13, 2010
(this “Agreement”),
by and between Bison Capital Equity Partners II-A, L.P., a Delaware limited
partnership, and Bison Capital Equity Partners II-B, L.P., a Delaware limited
partnership (collectively, “Purchaser”),
on the one hand, and The Center for Wound Healing, Inc., a Nevada corporation
(the “Company”),
on the other hand.  Any capitalized term used but not otherwise
defined herein shall have the same meaning as set forth in the Securities
Purchase Agreement dated as of March 31, 2008 by and between Purchaser and the
Company, as amended by the First Amendment to Securities Purchase Agreement
dated as of April 16, 2009, the Second Amendment to Securities Purchase
Agreement dated February 12, 2010, the Third Amendment to Securities Purchase
Agreement dated May 24, 2010 and the Fourth Amendment to Securities Purchase
Agreement dated September 17, 2010 (as otherwise amended, the “Securities
Purchase Agreement”).

     

    WHEREAS,
the Company has requested certain covenant adjustments from Purchaser;
and

     

    WHEREAS,
the parties desire to waive and amend certain provisions of the Securities
Purchase Agreement subject to the terms and conditions set forth
herein.

     

    NOW,
THEREFORE, in consideration of the premises and mutual covenants contained
herein, and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the parties agree as
follows:

     

    1.           The
definition of “Consolidated
Adjusted EBITDA” set forth in Section 1.1 of the
Agreement is hereby amended and restated in its entirety to read as
follows:

    

    The
definition of “Consolidated
Adjusted EBITDA” set forth in Section 1.1 of the
Agreement is hereby amended and restated in its entirety to read as
follows:

    

    “Consolidated
Adjusted EBITDA" shall mean, with respect to the Company and its
Subsidiaries during a specified period of time, the sum of the following, each
calculated for such period:

     

    (a)
Consolidated Net Income before taxes for such period (excluding (i) pre-tax
gains on the sale of assets, (ii) other pre-tax extraordinary or non-recurring
gains and (iii) any non-cash adjustments resulting from the existence of any
embedded derivatives contained in the Warrant Agreement or arising from the
issuance of Warrant Securities as may be required by FASB Statement No. 133 or
EITF Issue No. 00-19);

    
      
         

      

      
        -1-

        
          

        

      

      
         

      

    

     

    plus

     

    (b) the
sum of the following without duplication and to the extent reflected as a charge
in the statement of such net income for such period:  (i) interest
expense, (ii) depreciation, (iii) amortization, (iv) any non-cash stock
compensation expense, (v) any non-cash expense resulting from the issuance of
the Warrant and the Note, (vi) solely for purposes of measuring the Consolidated
Adjusted EBITDA for any quarter in fiscal year 2008,  up to $1,000,000 in
the aggregate of non-recurring expenses that are identified in amounts of
the end of each quarter of fiscal year 2008 when publicly filed that are
reasonably approved (as non-recurring expenses) by Purchaser and that were
included in the calculation of Consolidated Net Income during such quarter,
and (v) each of the following amounts (without duplication) (collectively, the
“Addbacks”),
provided, that
each Addback shall only be taken into account in the calculation of Consolidated
Adjusted EBITDA (1) for purposes of determining compliance with Section 9.18(a) and
(2) for the month in which the expense related to such Addback (as described
below) was recognized:

     

    (A) up to
$358,859 related to expense recognized in the quarter ended June 30, 2009 to
write off receivables from revenue recognized prior to December 31, 2008 and due
from St. John’s and St. Mary’s hospitals;

     

    (B) up to
$900,000 related to expense recognized in the quarter ended June 30, 2009 to
write off receivables from revenue recognized prior to December 31, 2008 and due
from parties other than St. John’s and St. Mary’s hospitals;

     

    (C) up to
$133,445 related to expense recognized in the quarter ended September 30, 2009
associated with the Toomey litigation;

     

    (D) up to
$8,865 related to expense recognized in the quarter ended September 30, 2009 and
$40,368 in the quarter ended December 31, 2009 associated with Med Air legal
expenses;

     

    (E) up to
$118,747 related to expense recognized in the quarter ended December 31, 2009
associated with the Morris and Boyer settlement;

     

    (F) up to
$155,872 related to expense recognized in the quarter ended December 31, 2009
associated with the Company’s financial statement restatement;

     

    (G) up to
$41,369 related to expense recognized in the quarter ended December 31, 2009
associated with the Company’s tax disclosure footnote restatement and
correction;

     

    (H) up to
$45,612 related to expense recognized in the quarter ended December 31, 2009
associated with capital raising activities;

     

    (I)
$500,000 in the quarter ended March 31, 2010;

     

    
      
         

      

      
        -2-

        
          

        

      

      
         

      

    

     

    (J)
$1,800,000 related to expense recognized in the quarter ended March 31, 2010 to
write off receivables from revenue recognized prior to July 1,
2009;

     

    (K)
$88,000 related to expense recognized in the quarter ended March 31, 2010 to
write off receivables from revenue recognized within the fiscal year ended June
30, 2010 prior to the quarter ended March 31, 2010; and

     

    (L)
$63,000 related to expense recognized in the quarter ended June 30, 2010 to
write off receivables from revenue recognized within the fiscal year ended June
30, 2010 prior to the quarter ended December 31, 2009.

     

    minus

     

    (c) each
of the following:

     

    (i)
interest income calculated in determining net income for such
period;

     

    (ii) for
the quarter ended December 31, 2009, the amount of the Addback described in
clause (b)(v)(K) immediately above;

     

    (iii) for
the quarter ended September 30, 2009 the amount of the Addback described in
clause (b)(v)(L) immediately above;

     

    provided, that
(A) the Consolidated Adjusted EBITDA of any Person or business disposed of
for consideration by any Credit Party during such period shall be excluded for
such period (the consummation of such disposition and the repayment of any
Indebtedness in connection therewith shall be assumed to have occurred on the
first day of such period); (B) Consolidated Adjusted EBITDA shall not include
any income of a Person that is not consolidated with the Company or that cannot
be distributed to the Company due to any Contractual Obligation or Requirement
of Law; and (C) all amounts included in or excluded from this definition shall
be calculated in accordance with GAAP.”

     

    2.           Section
10.1(v) of the Securities Purchase Agreement is hereby amended to change the
reference of “March 31, 2011” in clause (a) of such Section 10.1(v) to “July 1,
2011”.

     

    3.           Each
of the Company, its subsidiaries, affiliates, officers, directors and
representatives (together, the “Releasing
Parties”) fully releases and discharges forever Purchaser and its current
and former agents, employees, officers, directors, owners, partners,
shareholders, trustees, representatives, attorneys, subsidiaries, divisions,
related corporations, assigns, successors, and affiliated organizations
(hereafter referred to collectively as the “Released
Parties”), and each and all of them, from any and all liabilities,
claims, causes of action, charges, complaints, obligations, costs, losses,
damages, injuries, attorneys’ fees, and other legal responsibilities, of any
form whatsoever, whether known or unknown, unforeseen, unanticipated,
unsuspected or latent, which the Releasing Parties have incurred or expect to
incur, or now own or hold, or have at any time heretofore owned or held, or may
at any time own, hold, or claim to hold by reason of any matter or thing arising
from any cause whatsoever prior to the date of this Agreement.  This
Agreement does not purport to release claims that cannot be released as a matter
of law.

     

    
      
         

      

      
        -3-

        
          

        

      

      
         

      

    

     

    Each
Releasing Party acknowledges and intends that the Released Parties are being
released from unknown and unforeseen claims to the fullest extent permitted by
law and each Releasing Party waives any defenses based thereon.  Each
Releasing Party expressly waives and relinquishes all rights and benefits that
the Releasing Party may have under any statute or other applicable law
comparable to Section 1542 of the California Civil Code, which Section 1542 is
intended to protect against an inadvertent release of unknown or unsuspected
claims, and reads as follows:

    

    “Section
1542. [General Release; extent.] A general release does not extend to claims
which the creditor does not know or suspect to exist in his or her favor at the
time of executing the release, which if known by him or her must have materially
affected his or her settlement with the debtor.”

     

    Each
Releasing Party, being aware of said Section 1542, hereby expressly waives any
rights the Releasing Party may have under any statutes, other applicable law or
common law principles of similar effect, with respect to the claims purported to
be released hereby.

     

    Each
Releasing Party covenants and agrees never to commence, prosecute or assist in
any way, or cause, permit or advise to be commenced or prosecuted, any action,
proceeding, or discovery against any Released Party based on any released
claim.

     

    Each
Releasing Party agrees to indemnify and hold Purchaser and the other persons and
entities released by this Agreement harmless from and against any and all claims
arising from or in connection with any action or proceeding brought by it or for
its benefit or on its initiative contrary to the provisions of this
Agreement.  This Agreement shall be deemed breached and a cause of
action shall accrue immediately upon the commencement of any action or
proceeding contrary to this Agreement, and in any such action or proceeding this
Agreement may be pleaded as a defense by any person or entity released by this
Agreement, or may be asserted by way of cross-complaint, counterclaim or
cross-claim in any such action or proceeding.

     

    4.           In
partial consideration of Purchaser’s agreement to enter into this Agreement, the
Company shall, within 3 business days of demand therefor, reimburse Purchaser
for all attorneys’ fees and expenses actually incurred by or on behalf of
Purchaser pursuant to, in respect of or otherwise in connection with this
Agreement or the Existing Default.  The payment of all such amounts
shall be made by wire transfer of immediately available funds to an account
designated by Purchaser.

     

    5.           This
Agreement amends the Securities Purchase Agreement and all references to the
Securities Purchase Agreement shall be deemed to incorporate this
Agreement.  All other terms and conditions of the Transaction
Documents shall remain in full force and effect and shall not be affected by
this Agreement.

     

    
      
         

      

      
        -4-

        
          

        

      

      
         

      

    

     

    6.           This
Agreement may be executed in any number of counterparts, each of which shall be
deemed to be an original as against any party whose signature appears hereon,
and all of which shall together constitute one and the same
instrument.  This Agreement shall become binding when one or more
counterparts hereof, individually or taken together, shall bear the signatures
of all of the parties reflected hereon as the signatories.

     

    7.           Sections 14.5, 14.6, 14.7 and 14.8 of the
Securities Purchase Agreement are hereby incorporated by reference and made a
part of this Agreement mutatis
mutandis, except that the references therein to “this Agreement” shall
include this Agreement.

     

    [Signature
Page Follows]

    
      
         

      

      
        -5-

        
          

        

      

      
         

      

    

    IN
WITNESS WHEREOF, the parties hereto have each caused this Agreement to be duly
signed as of the date first above written.

     

    
      
        	 
      	
                BISON
      CAPITAL EQUITY PARTNERS

                II-A,
      L.P.

              
	 
      	 
      
	 
      	
                By:
      BISON CAPITAL PARTNERS II,

                LLC,
      its general partner

              
	 
      	 
      
	 
      	
                By:

              	
                /s/ Peter S. Macdonald

              
	 
      	
                Name: 

              	
                Peter
      S. Macdonald

              
	 
      	
                Title:

              	
                Managing
      Member

              
	 
      	 
      	 
      
	 
      	
                BISON
      CAPITAL EQUITY PARTNERS

                II-B,
      L.P.

              
	 
      	 
      
	 
      	
                By:
      BISON CAPITAL PARTNERS II,

                LLC,
      its general partner

              
	 
      	 
      
	 
      	
                By:

              	
                /s/ Peter S. Macdonald

              
	 
      	
                Name:

              	
                Peter
      S. Macdonald

              
	 
      	
                Title:

              	
                Managing
      Member

              
	 
      	 
      	 
      
	 
      	
                THE
      CENTER FOR WOUND HEALING,

                INC.

              
	 
      	 
      	 
      
	 
      	
                By:

              	
                /s/ Andrew G. Barnett

              
	 
      	
                Name:

              	
                Andrew
      G. Barnett

              
	 
      	
                Title:

              	
                Chief
      Executive Officer

              

      

    

    

    Signature
Page of Fifth AmendmentExhibit 10.18

     

    
      
        

      

    

     

    WAIVER
AND NINTH AMENDMENT

    DATED
AS OF OCTOBER 13, 2010

    IN
RESPECT OF

    AMENDED
AND RESTATED LOAN AGREEMENT

    

    BY
AND AMONG

    

    CFWH
(Delaware), LLC, CFWH (Massachusetts), LLC, CFWH (New Jersey) LLC,

    CFWH
(New York) LLC, New York Hyperbaric And Wound Care Centers, L.L.C.,
The

    Square
Hyperbaric LLC, CFWH (Pennsylvania), LLC, and THE CENTER FOR WOUND

    HEALING,
INC.

    

    AND

    

    SIGNATURE
BANK

    

    
      
        

      

    

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    THIS
WAIVER AND NINTH AMENDMENT (the “Waiver-Amendment”) made as of the 13th day of
October, 2010 by and among CFWH (Delaware), LLC, CFWH (Massachusetts), LLC, CFWH
(New Jersey) LLC, CFWH (New York) LLC, New York Hyperbaric And Wound Care
Centers, L.L.C., The Square Hyperbaric LLC, CFWH (Pennsylvania), LLC, and THE
CENTER FOR WOUND HEALING, INC., each with a place of business at 155 White
Plains Road, Tarrytown, NY  10591 (the foregoing Persons, individually
and collectively, the “Borrower”), and SIGNATURE BANK, a New York bank having an
office at 1225 Franklin Avenue, Garden City, New York 11530 (the
“Bank”).

    

    WITNESSETH:

    

    WHEREAS,
certain of the entities comprising the Borrower and the Bank entered into a
Amended and Restated Loan Agreement dated as of June 17, 2005 as amended by a
First Amendment dated as of April 7, 2006, a Second Amendment dated as of
February 1, 2007, a Third Amendment and Waiver dated as of May 29, 2007, a
Fourth Amendment and Waiver dated as of July 31, 2007, a Fifth Amendment dated
as of October 11, 2007, a Sixth Amendment dated as of March 19, 2008, a Seventh
Amendment dated as of June 30, 2008 and an Eighth Amendment dated as of December
18, 2008 (collectively, the “Agreement”), providing for certain financial
accommodations to the Borrower and which Agreement is now in full force and
effect;

    

    WHEREAS, the Borrower has failed to
comply with the provisions of Sections 6.1, 6.3 and 6.5 of the Agreement, and
the Borrower has informed the Bank that it will in the future fail to comply
with the provisions of Section 6.4 of the Agreement, all as described
below;

    

    WHEREAS,
the Borrower and the Bank desire that the Bank waives the Borrowers’
non-compliance with such provisions of the Agreement on the terms and conditions
hereinafter set forth; and

    

    WHEREAS,
the Borrower and the Bank desire to extend the Termination Date on the terms and
conditions hereinafter set forth;

    

    NOW,
THEREFORE, in consideration of the premises and the agreements hereinafter set
forth and for other good and valuable consideration, the receipt and sufficiency
of which is hereby acknowledged, the parties hereto agree as
follows:

    

    1.           As
used in this Waiver-Amendment, capitalized terms, unless otherwise defined,
shall have the meanings ascribed thereto in the Agreement.

    
      
         

      

      
        1

        
          

        

      

      
         

      

    

    2.           The
Borrower failed to comply with the provisions of Section 6.1 of the Agreement
for the four fiscal quarter period of the Borrower ended June 30, 2010, as the
ratio which is the subject of such section was 0.26:1.00 for such
period.  Such non-compliance is hereby waived, for the four fiscal
quarter period of the Borrower ended June 30, 2010, for each of the four fiscal
quarter periods ending subsequent to June 30, 2010 through and including the
four fiscal quarter period ending June 30, 2011, and for July 1, 2011, provided
that (a) such ratio was not less than 0.26:1.00 for the four fiscal quarter
period of the Borrower ended June 30, 2010, and (b) such ratio will not be, for
the four fiscal quarter period ending: (i) September 30, 2010, less than
0.45:1.00; (ii) December 31, 2010, less than 0.20:1.00; (iii) March 31, 2011,
less than 0.35:1.00; or (iv) June 30, 2011, or for July 1, 2011, less than
0.50:1.00.  Notwithstanding anything contained in this
Waiver-Amendment or in the Agreement to the contrary, solely for purposes of
determining the Borrower’s compliance with the provisions of the section of the
Agreement which is the subject of this paragraph, and solely for the periods or
date(s) which are the subject of this paragraph, there shall be added to EBITDA
of the Borrower, without duplication, the following items for the periods or
date(s) to which such items relate (as determined in accordance with
GAAP):  (1) $228,000 relating solely to and comprised solely of
litigation expenses and 2009 10-K restatement expenses incurred during the
fiscal quarter ended September 30, 2009; (2) $276,000 relating solely to and
comprised solely of litigation expenses, 2009 10-K restatement expenses and
expenses relating solely and directly to the sale of the Borrower incurred
during the fiscal quarter ended December 31, 2009; (3) $2,131,000 relating
solely to and comprised solely of bad debt write-offs taken during the fiscal
quarter ended March 31, 2010, litigation expenses and expenses relating solely
and directly to the sale of the Borrower incurred during the fiscal quarter
ended March 31, 2010, and the Borrower’s correction of the Apligraph billing
error by refunding the applicable amount during the fiscal quarter ended March
31, 2010; and (4) $132,000 relating solely to litigation expenses and expenses
relating solely and directly to the sale of the Borrower incurred during the
fiscal quarter ended June 30, 2010.

    

    3.           The
Borrower failed to comply with the provisions of Section 6.3 of the Agreement as
of the last day of the fiscal quarter of the Borrower ended June 30, 2010, as
the Effective Tangible Net Worth as the Borrower as of June 30, 2010 was
$12,035,342.  Such non-compliance is hereby waived, as of the last day
of the fiscal quarter of the Borrower ended June 30, 2010, as of the last day of
each fiscal quarter of the Borrower occurring subsequent to June 30, 2010
through and including June 30, 2011, and as of July 1, 2011, provided that (a)
the Effective Tangible Net Worth of the Borrower as of June 30, 2010 was not
less than $12,035,342, and (b) the Effective Tangible Net Worth of the Borrower
will not be, as of: (i) September 30, 2010, less than $12,000,000; (ii) December
31, 2010, less than $11,300,000; (iii) March 31, 2011, less than $8,500,000; or
(iv) June 30, 2011 or July 1, 2011, less than $8,800,000.

    

    4.           The
Borrower has informed the Bank that it is in compliance with the provisions of
Section 6.4 of the Agreement for the four fiscal quarter period of the Borrower
ended June 30, 2010, as the ratio which is the subject of such section was
0.24:1.00 for such period and as of such date, but that the Borrower will fail
to be in compliance with the provisions of such section for the four fiscal
quarter periods ending March 31, 2011 and June 30, 2011 (and as of such
dates).  Such non-compliance is hereby waived, provided that such
ratio will not be, for the four fiscal quarter period ending: (i) March 31, 2011
(or as of such date), more than 1.50:1.00; or (ii) June 30, 2011 (or as of such
date), or for July 1, 2011 (or as of such date), more than
1.25:1.00.  Notwithstanding anything contained in this
Waiver-Amendment or in the Agreement to the contrary, solely for purposes of
determining the Borrower’s compliance with the provisions of the section of the
Agreement which is the subject of this paragraph, and solely for the periods or
date(s) which are the subject of this paragraph, there shall be added to EBITDA
of the Borrower, without duplication, the following items for the periods or
date(s) to which such items relate (as determined in accordance with
GAAP):  (1) $228,000 relating solely to and comprised solely of
litigation expenses and 2009 10-K restatement expenses incurred during the
fiscal quarter ended September 30, 2009; (2) $276,000 relating solely to and
comprised solely of litigation expenses, 2009 10-K restatement expenses and
expenses relating solely and directly to the sale of the Borrower incurred
during the fiscal quarter ended December 31, 2009; (3) $2,131,000 relating
solely to and comprised solely of bad debt write-offs taken during the fiscal
quarter ended March 31, 2010, litigation expenses and expenses relating solely
and directly to the sale of the Borrower incurred during the fiscal quarter
ended March 31, 2010, and the Borrower’s correction of the Apligraph billing
error by refunding the applicable amount during the fiscal quarter ended March
31, 2010; and (4) $132,000 relating solely to litigation expenses and expenses
relating solely and directly to the sale of the Borrower incurred during the
fiscal quarter ended June 30, 2010.

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

    

    5.           The
Borrower failed to comply with the provisions of Section 6.5 of the Agreement
for the four fiscal quarter period of the Borrower ended June 30, 2010, as the
ratio which is the subject of such section was 6.97:1.00 for such period and as
of such date.  Such non-compliance is hereby waived, for the four
fiscal quarter period of the Borrower ended June 30, 2010 (and as of such date),
for each of the four fiscal quarter periods ending subsequent to June 30, 2010
(and as of such dates) through and including the four fiscal quarter period
ending June 30, 2011 (and as of such date), and for July 1, 2011 (and as of such
date), provided that (a) the ratio which is the subject of such section was not
more than 6.97:1.00 for the four fiscal quarter period of the Borrower ended
June 30, 2010 (or as of such date), and (b) such ratio will not be, for the four
fiscal quarter period ending: (i) September 30, 2010 (or as of such date), more
than 3.85:1.00; (ii) December 31, 2010 (or as of such date), more than
5.25:1.00; (iii) March 31, 2011 (or as of such date), more than 4.50:1.00; or
(iv) June 30, 2011 (or as of such date), or for July 1, 2011 (or as of such
date), more than 4.00:1.00.  Notwithstanding anything contained in
this Waiver-Amendment or in the Agreement to the contrary, solely for purposes
of determining the Borrower’s compliance with the provisions of the section of
the Agreement which is the subject of this paragraph, and solely for the periods
or date(s) which are the subject of this paragraph, there shall be added to
EBITDA of the Borrower, without duplication, the following items for the periods
or date(s) to which such items relate (as determined in accordance with
GAAP):  (1) $228,000 relating solely to and comprised solely of
litigation expenses and 2009 10-K restatement expenses incurred during the
fiscal quarter ended September 30, 2009; (2) $276,000 relating solely to and
comprised solely of litigation expenses, 2009 10-K restatement expenses and
expenses relating solely and directly to the sale of the Borrower incurred
during the fiscal quarter ended December 31, 2009; (3) $2,131,000 relating
solely to and comprised solely of bad debt write-offs taken during the fiscal
quarter ended March 31, 2010, litigation expenses and expenses relating solely
and directly to the sale of the Borrower incurred during the fiscal quarter
ended March 31, 2010, and the Borrower’s correction of the Apligraph billing
error by refunding the applicable amount during the fiscal quarter ended March
31, 2010; and (4) $132,000 relating solely to litigation expenses and expenses
relating solely and directly to the sale of the Borrower incurred during the
fiscal quarter ended June 30, 2010.

    

    6.           Notwithstanding
anything contained in this Waiver-Amendment to the contrary, the Borrowers’
non-compliance with Section 6, for all fiscal quarters and financial covenant
testing dates ending/occurring subsequent to June 30, 2010 and ending/occurring
on or prior to July 1, 2011, is hereby waived to the extent and solely to the
extent resulting from the required adoption by the Borrower of changes in GAAP
(relating to GAAP Codification of Accounting Standards Codification Topic
470:Debt) from and after June 30, 2009 and through and including July 1,
2011.

    
      
         

      

      
        3

        
          

        

      

      
         

      

    

    

    7.           The
definition of the term “Termination Date” shall be deleted, and in lieu thereof,
the following shall be inserted:

    

    “Termination Date”
shall mean the earlier of (a) July 1, 2011, or if such date is not a Business
Day, the Business Day next succeeding such date; or (b) the date the Commitment
is terminated pursuant to Section 8 hereof.

    

    8.           As
an inducement for the Bank to enter into this Waiver-Amendment, the Borrower
hereby represents and warrants as follows:

    

    (A)           There
are no defenses or offsets to its obligations under the Agreement, the Note or
any of the other agreements in favor of the Bank referred to in the Agreement,
and if any such defenses or offsets exist without the knowledge of the Borrower,
the same are hereby waived.

    

    (B)           All
the representations and warranties made by the Borrower in the Agreement are
true and correct in all material respects as if made on the date
hereof.

    

    8.           It
is expressly understood and agreed that all collateral security for the Loans
set forth in the Agreement prior to the waiver provided for herein, is and shall
continue to be collateral security for the Loans and other extensions of credit
provided under the Agreement as herein modified.  Without limiting the
generality of the foregoing, the Borrower hereby absolutely and unconditionally
confirms that each document and instrument executed by the Borrower pursuant to
the Agreement continues in full force and effect, is ratified and confirmed and
is and shall continue to be applicable to the Agreement (both before and after
giving effect to this Waiver-Amendment).

    

    9.           By
their execution of this letter in the space provided below, the Guarantors (if
any) hereby consent to this Waiver-Amendment and reaffirm their continuing
liability under their guarantees in respect of the Agreement, as amended hereby,
and all documents, instruments and agreements executed pursuant thereto or in
connection therewith, without offset, defense or counterclaim (any such offset,
defense or counterclaim as may exist being hereby irrevocably waived by any such
Guarantors).

    

    10.         The
Waiver-Amendment set forth herein is limited precisely as written and shall not
be deemed (except as the Agreement is modified by this Waiver-Amendment) to (a)
be a consent to or a waiver of any term or condition of the Agreement (i.e.,
only non-compliance with the above-referenced sections of the Agreement, but not
with any other sections of the Agreement is waived hereby or any of the
documents referred to therein, or (b) prejudice any right or rights which the
Bank may now have or may have in the future under or in connection with the
Agreement or any documents referred to therein.  Whenever the
Agreement is referred to in the Agreement or any of the instruments, agreements
or other documents or papers executed and delivered in connection therewith, it
shall be deemed to mean the Agreement as modified by this
Waiver-Amendment.  This Waiver-Amendment may be signed in one or more
counterparts which, when taken together, shall constitute one and the same
document.  The parties to this Waiver-Amendment agree that, for
purposes of the execution of this Waiver-Amendment, facsimile signatures and
scanned signatures through email will constitute original
signatures.

    
      
         

      

      
        4

        
          

        

      

      
         

      

    

    

    11.         This
Waiver-Amendment shall become effective on such date as all of the following
conditions have been satisfied:

    

    (A)           Waiver-Amendment
Fee.  The Borrower shall have paid to the Bank a
waiver-amendment fee in the amount of $10,000.00; and

     

    (B)           Fees and
Expenses.  The Bank shall have received evidence of payment of
the fees and disbursements of the Bank’s counsel (if invoiced by the Bank’s
counsel on or prior to the date hereof).

    

    12.         This
Waiver-Amendment is dated of October 13, 2010 and shall be effective on the date
of execution by the Bank.  Except as modified by this
Waiver-Amendment, the Agreement is in all respects ratified and
confirmed.

    
      
         

      

      
        5

        
          

        

      

      
         

      

    

    

    IN
WITNESS WHEREOF, the parties hereto have caused this Waiver-Amendment to be
executed by their duly authorized officers as of the date first written
above.

    

    
      
        	
                Borrower:

              
	
                CFWH
      (Delaware), LLC

              
	
                CFWH
      (Massachusetts), LLC

              
	
                CFWH
      (New Jersey) LLC

              
	
                CFWH
      (New York) LLC

              
	
                New
      York Hyperbaric And Wound Care Centers, L.L.C.

              
	
                The
      Square Hyperbaric LLC

              
	
                CFWH
      (Pennsylvania), LLC

              
	
                Each
      by its manager/member,

              
	
                THE
      CENTER FOR WOUND HEALING, INC.

              
	 
      	 
      
	
                By:

              	
                /s/ Andrew G. Barnett

              
	 
      	
                Andrew
      G. Barnett

              
	 
      	
                Chief
      Executive Officer

              
	 
      	 
      
	
                THE
      CENTER FOR WOUND HEALING, INC.

              
	 
      	 
      
	
                By:

              	
                /s/ Andrew G. Barnett

              
	 
      	
                Andrew
      G. Barnett

              
	 
      	
                Chief
      Executive Officer

              
	 
      	 
      
	
                Bank:

              
	
                SIGNATURE
      BANK

              
	 
      	 
      
	
                By:

              	
                /s/ Lori Cabana

              
	 
      	
                Lori
      Cabana

              
	 
      	
                Vice
      President and Lender

              

      

    

     

    
      
         

      

      
        6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00179-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00179-of-00352.parquet"}]]